Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma

Oncology Reports

Volumn 37, Issue 5, 2017, Pages 2727-2734

  Ohshima, Mitsuyoshi ^a   Sugahara, Keisuke ^a   Kasahara, Kiyohiro ^a   Katakura, Akira ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Biomarker; Capillary electrophoresis mass spectrometry; Japanese; Metabolome; Oral squamous cell carcinoma; Saliva

Indexed keywords

2 HYDROXY 4 METHYLVALERIC ACID; 2 HYDROXYVALERIC ACID; 2 OXOISOVALERIC ACID; 3 (4 HYDROXYPHENYL)PROPIONIC ACID; 3 HYDROXYBUTYRIC ACID; 3 PHENYL LACTIC ACID; 4 HYDROXYPHENYLACETIC ACID; ALANINE; AMINO ACID DERIVATIVE; BUTYRIC ACID; CADAVERINE; CHOLINE; GAMMA BUTYROBETAINE; GLYCOLIC ACID; HEPTANOIC ACID; HEXANOIC ACID; HYDROCINNAMIC ACID; ISOLEUCINE; LACTIC ACID DERIVATIVE; LEUCINE; N6,N6,N6 TRIMETHYLLYSINE; OCTANOIC ACID; PROPIONIC ACID DERIVATIVE; TAURINE; TEREPHTHALIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG; UREA; VALERIC ACID DERIVATIVE; VALINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; JAPANESE (PEOPLE); MALE; MASS SPECTROMETRY; METABOLOMICS; MOUTH SQUAMOUS CELL CARCINOMA; SALIVA ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; METABOLISM; METABOLOME; MIDDLE AGED; MOUTH TUMOR; PROCEDURES; SALIVA; SQUAMOUS CELL CARCINOMA;

3-HYDROXYBUTYRIC ACID; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MIDDLE AGED; MOUTH NEOPLASMS; SALIVA;

EID: 85018723906     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2017.5561     Document Type: Article

References (38)

1. Sudbø J: Novel management of oral cancer: A paradigm of predictive oncology. Clin Med Res 2: 233-242, 2004.
2. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs E.J., Schymura MJ, Noone AM, Pan L, Anderson R.N., Fulton JE, Kohler BA, et al: Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118: 2338-2366, 2012.
3. Genden EM, Ferlito A, Bradley P.J., Rinaldo A and Scully C: Neck disease and distant metastases. Oral Oncol 39: 207-212, 2003.
4. Sabichi AL, Demierre MF, Hawk E.T., Lerman CE and Lippman SM: Frontiers in cancer prevention research. Cancer Res 63: 5649-5655, 2003.
5. Spafford MF, Koch WM, Reed A.L., Califano JA, Xu LH, Eisenberger CF, Yip L, Leong P.L., Wu L., Liu SX, et al: Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 7: 607-612, 2001.
6. Sugimoto M, Wong DT, Hirayama A, Soga T and Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6: 78-95, 2010.
7. Katakura A, Yamamoto N, Sakuma T., Sugahara K, Onda T, Noguchi S and Shibahara T: A screening test for oral cancer using saliva samples: Proteomic analysis of biomarkers in whole saliva. J Oral Maxillofac Surg 27: 1-5, 2015
8. Soga T, Baran R, Suematsu M., Ueno Y, Ikeda S, Sakurakawa T., Kakazu Y, Ishikawa T, Robert M., Nishioka T, et al: Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281: 16768-16776, 2006.
9. Kind T and Fiehn O: Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics 7: 234, 2006.
10. Kind T and Fiehn O: Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics 8: 105, 2007
11. Sugimoto M, Kikuchi S, Arita M., Soga T, Nishioka T and Tomita M: Large-scale prediction of cationic metabolite identity and migration time in capillary electrophoresis mass spectrometry using artificial neural networks. Anal Chem 77: 78-84, 2005
12. Goto S, Okuno Y, Hattori M., Nishioka T and Kanehisa M: LIGAND: Database of chemical compounds and reactions in biological pathways. Nucleic Acids Res 30: 402-404, 2002.
13. Wishart DS, Tzur D, Knox C., Eisner R, Guo AC, Young N, Cheng D., Jewell K, Arndt D, Sawhney S., et al: HMDB: The human metabolome database. Nucleic Acids Res 35: D521-D526, 2007
14. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993.
15. Banks RE, Dunn MJ, Hochstrasser D.F., Sanchez JC, Blackstock W, Pappin DJ and Selby PJ: Proteomics: New perspectives, new biomedical opportunities. Lancet 356: 1749-1756, 2000.
16. Li Y, St John MA, Zhou X, Kim Y, Sinha U., Jordan RC, Eisele D, Abemayor E, Elashoff D., Park NH, et al: Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10: 8442-8450, 2004
17. Takahama U, Imamura H and Hirota S: Nitration of the salivary component 4-hydroxyphenylacetic acid in the human oral cavity: Enhancement of nitration under acidic conditions. Eur J Oral Sci 117: 555-562, 2009
18. Warburg OH (ed): The metabolism of tumours: investigations from the Kaiser Wilhelm Institute for Biology, Berlin-Dahlem. Richard R. Smith Inc., New York, pp 129-169, 1931.
19. Hirayama A, Kami K, Sugimoto M., Sugawara M, Toki N, Onozuka H., Kinoshita T, Saito N, Ochiai A., Tomita M, et al: Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69: 4918-4925, 2009
20. Ackerstaff E, Glunde K and Bhujwalla ZM: Choline phospholipid metabolism: A target in cancer cells? J Cell Biochem 90: 525-533, 2003.
21. Katz-Brull R., Seger D, Rivenson-Segal D, Rushkin E and Degani H: Metabolic markers of breast cancer: Enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 62: 1966-1970, 2002.
22. Haddadin IS, Mcintosh A, Meisamy S., Corum C, Styczynski Snyder AL, Powell NJ, Nelson MT, Yee D, Garwood M and Bolan PJ: Metabolite quantification and high-field MRS in breast cancer. NMR Biomed 22: 65-76, 2009
23. Katz-Brull R., Margalit R and Degani H: Differential routing of choline in implanted breast cancer and normal organs. Magn Reson Med 46: 31-38, 2001.
24. Harris RA, Zhang B, Goodwin G.W., Kuntz MJ, Shimomura Y, Rougraff P, Dexter P., Zhao Y, Gibson R and Crabb DW: Regulation of the branched-chain alpha-ketoacid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease. Adv Enzyme Regul 30: 245-263, 1990.
25. Mustafa A, Gupta S, Hudes G.R., Egleston BL, Uzzo RG and Kruger WD: Serum amino acid levels as a biomarker for renal cell carcinoma. J Urol 186: 1206-1212, 2011.
26. Ma Y, Zhang P, Wang F., Liu W, Yang J and Qin H: An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer. Ann Surg 255: 720-730, 2012.
27. Gaudet MM, Falk RT, Stevens R.D., Gunter MJ, Bain JR, Pfeiffer RM, Potischman N, Lissowska J., Peplonska B, Brinton LA, et al: Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. J Clin Endocrinol Metab 97: 3216-3223, 2012.
28. Cross AJ, Moore SC, Boca S, Huang W.Y., Xiong X., Stolzenberg-Solomon R, Sinha R and Sampson JN: A prospective study of serum metabolites and colorectal cancer risk. Cancer 120: 3049-3057, 2014
29. Willems L, Jacque N, Jacquel A., Neveux N, Maciel TT, Lambert M, Schmitt A., Poulain L, Green AS, Uzunov M, et al: Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood 122: 3521-3532, 2013.
30. Ye N, Liu C and Shi P: Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy. Eur J Gynaecol Oncol 36: 174-180, 2015
31. Deja S, Porebska I, Kowal A., Zabek A, Barg W, Pawelczyk K., Stanimirova I, Daszykowski M, Korzeniewska A., Jankowska R, et al: Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. J Pharm Biomed Anal 100: 369-380, 2014
32. De Luca V., Viggiano E, Messina G., Viggiano A, Borlido C, Viggiano A and Monda M: Peripheral amino acid levels in schizophrenia and antipsychotic treatment. Psychiatry Investig 5: 203-208, 2008.
33. Liang Q, Wang C and Li B: Metabolomic analysis using liquid chromatography/mass spectrometry for gastric cancer. Appl Biochem Biotechnol 176: 2170-2184, 2015
34. Shirai M: Transcription regulation of the urease operon in Helicobacter pyiori in response to pH and mechanisms of stable colonizaion in the stomach. Yamaguchi Med 50: 593-601, 2001.
35. Hilvo M, de Santiago I, Gopalacharyulu P, Schmitt W.D., Budczies J., Kuhberg M, Dietel M, Aittokallio T., Markowetz F, Denkert C, et al: Accumulated metabolites of hydroxybutyric acid serve as diagnostic and prognostic biomarkers of ovarian high-grade serous carcinomas. Cancer Res 76: 796-804, 2016.
36. Zeng J, Yin P, Tan Y., Dong L, Hu C, Huang Q., Lu X, Wang H and Xu G: Metabolomics study of hepatocellular carcinoma: Discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry. J Proteome Res 13: 3420-3431, 2014
37. OuYang D, Xu J, Huang H and Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol 165: 148-154, 2011.
38. Hur H, Paik MJ, Xuan Y, Nguyen D.T., Ham IH, Yun J, Cho YK, Lee G and Han SU Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer. PLoS One 9: e98581, 2014